CHS INC - CHSINC 7.1 PERP (CHSCN) Stock Fundamental Analysis

NASDAQ:CHSCN • US12542R5063

25.47 USD
0 (0%)
Last: Feb 20, 2026, 04:30 PM
Fundamental Rating

3

Taking everything into account, CHSCN scores 3 out of 10 in our fundamental rating. CHSCN was compared to 88 industry peers in the Food Products industry. There are concerns on the financial health of CHSCN while its profitability can be described as average. CHSCN has a expensive valuation and it also scores bad on growth. CHSCN also has an excellent dividend rating.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

  • In the past year CHSCN had a positive cash flow from operations.
  • CHSCN had positive earnings in each of the past 5 years.
  • CHSCN had a positive operating cash flow in each of the past 5 years.
CHSCN Yearly Net Income VS EBIT VS OCF VS FCFCHSCN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 1B 2B 3B

1.2 Ratios

  • The Return On Assets of CHSCN (2.96%) is comparable to the rest of the industry.
  • Looking at the Return On Equity, with a value of 5.48%, CHSCN is in the better half of the industry, outperforming 61.36% of the companies in the same industry.
  • The Return On Invested Capital of CHSCN (0.37%) is comparable to the rest of the industry.
  • Measured over the past 3 years, the Average Return On Invested Capital for CHSCN is significantly below the industry average of 28.12%.
Industry RankSector Rank
ROA 2.96%
ROE 5.48%
ROIC 0.37%
ROA(3y)6.36%
ROA(5y)6.23%
ROE(3y)11.28%
ROE(5y)11.55%
ROIC(3y)3.89%
ROIC(5y)4.02%
CHSCN Yearly ROA, ROE, ROICCHSCN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15

1.3 Margins

  • With a Profit Margin value of 1.75%, CHSCN perfoms like the industry average, outperforming 55.68% of the companies in the same industry.
  • CHSCN's Profit Margin has improved in the last couple of years.
  • CHSCN has a Operating Margin (0.21%) which is comparable to the rest of the industry.
  • In the last couple of years the Operating Margin of CHSCN has declined.
  • With a Gross Margin value of 3.21%, CHSCN is not doing good in the industry: 80.68% of the companies in the same industry are doing better.
  • In the last couple of years the Gross Margin of CHSCN has remained more or less at the same level.
Industry RankSector Rank
OM 0.21%
PM (TTM) 1.75%
GM 3.21%
OM growth 3Y-52.33%
OM growth 5Y-23.53%
PM growth 3Y-21.71%
PM growth 5Y2.56%
GM growth 3Y-10.36%
GM growth 5Y-1.5%
CHSCN Yearly Profit, Operating, Gross MarginsCHSCN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1 2 3 4 5

3

2. Health

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so CHSCN is destroying value.
  • The debt/assets ratio for CHSCN is higher compared to a year ago.
CHSCN Yearly Shares OutstandingCHSCN Yearly Shares OutstandingYearly Shares Outstanding 2018 2M 4M 6M 8M 10M
CHSCN Yearly Total Debt VS Total AssetsCHSCN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B

2.2 Solvency

  • CHSCN has an Altman-Z score of 2.10. This is not the best score and indicates that CHSCN is in the grey zone with still only limited risk for bankruptcy at the moment.
  • CHSCN has a Altman-Z score (2.10) which is comparable to the rest of the industry.
  • CHSCN has a Debt/Equity ratio of 0.32. This is a healthy value indicating a solid balance between debt and equity.
  • CHSCN's Debt to Equity ratio of 0.32 is fine compared to the rest of the industry. CHSCN outperforms 62.50% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.32
Debt/FCF N/A
Altman-Z 2.1
ROIC/WACC0.07
WACC5.45%
CHSCN Yearly LT Debt VS Equity VS FCFCHSCN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 2B 4B 6B 8B 10B

2.3 Liquidity

  • A Current Ratio of 1.42 indicates that CHSCN should not have too much problems paying its short term obligations.
  • CHSCN's Current ratio of 1.42 is in line compared to the rest of the industry. CHSCN outperforms 44.32% of its industry peers.
  • A Quick Ratio of 0.80 indicates that CHSCN may have some problems paying its short term obligations.
  • The Quick ratio of CHSCN (0.80) is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 1.42
Quick Ratio 0.8
CHSCN Yearly Current Assets VS Current LiabilitesCHSCN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B

1

3. Growth

3.1 Past

  • CHSCN shows a decrease in Revenue. In the last year, the revenue decreased by -5.74%.
  • The Revenue has been growing slightly by 4.54% on average over the past years.
EPS 1Y (TTM)N/A
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)-5.74%
Revenue growth 3Y-9.47%
Revenue growth 5Y4.54%
Sales Q2Q%-4.63%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
CHSCN Yearly Revenue VS EstimatesCHSCN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10B 20B 30B 40B

1

4. Valuation

4.1 Price/Earnings Ratio

Industry RankSector Rank
PE N/A
Fwd PE N/A
CHSCN Price Earnings VS Forward Price EarningsCHSCN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

  • 95.45% of the companies in the same industry are more expensive than CHSCN, based on the Enterprise Value to EBITDA ratio.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 2.36
CHSCN Per share dataCHSCN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 500 1K 1.5K 2K 2.5K

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

8

5. Dividend

5.1 Amount

  • With a Yearly Dividend Yield of 7.46%, CHSCN is a good candidate for dividend investing.
  • Compared to an average industry Dividend Yield of 2.27, CHSCN pays a better dividend. On top of this CHSCN pays more dividend than 90.91% of the companies listed in the same industry.
  • Compared to an average S&P500 Dividend Yield of 1.81, CHSCN pays a better dividend.
Industry RankSector Rank
Dividend Yield 7.46%

5.2 History

  • CHSCN has been paying a dividend for at least 10 years, so it has a reliable track record.
  • CHSCN has not decreased their dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years10
CHSCN Yearly Dividends per shareCHSCN Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.5 1 1.5

5.3 Sustainability

  • CHSCN pays out 27.52% of its income as dividend. This is a sustainable payout ratio.
DP27.52%
EPS Next 2YN/A
EPS Next 3YN/A
CHSCN Yearly Income VS Free CF VS DividendCHSCN Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500M 1B 1.5B 2B 2.5B
CHSCN Dividend Payout.CHSCN Dividend Payout, showing the Payout Ratio.CHSCN Dividend Payout.PayoutRetained Earnings

CHS INC - CHSINC 7.1 PERP

NASDAQ:CHSCN (2/20/2026, 4:30:02 PM)

25.47

0 (0%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryFood Products
Earnings (Last)01-06
Earnings (Next)03-31
Inst Owners11.23%
Inst Owner Change0%
Ins Owners0.04%
Ins Owner ChangeN/A
Market Cap312.52M
Revenue(TTM)35.03B
Net Income(TTM)613.61M
Analysts0
Price TargetN/A
Short Float %0.28%
Short Ratio1.6
Dividend
Industry RankSector Rank
Dividend Yield 7.46%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP27.52%
Div Incr Years0
Div Non Decr Years10
Ex-Date03-17
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.01
P/FCF N/A
P/OCF 0.53
P/B 0.03
P/tB 0.03
EV/EBITDA 2.36
EPS(TTM)N/A
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-4.86
FCFYN/A
OCF(TTM)48.25
OCFY189.42%
SpS2855.14
BVpS913.07
TBVpS913.07
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA 2.96%
ROE 5.48%
ROCE 0.54%
ROIC 0.37%
ROICexc 0.38%
ROICexgc 0.38%
OM 0.21%
PM (TTM) 1.75%
GM 3.21%
FCFM N/A
ROA(3y)6.36%
ROA(5y)6.23%
ROE(3y)11.28%
ROE(5y)11.55%
ROIC(3y)3.89%
ROIC(5y)4.02%
ROICexc(3y)4.33%
ROICexc(5y)4.38%
ROICexgc(3y)4.41%
ROICexgc(5y)4.46%
ROCE(3y)5.12%
ROCE(5y)5.34%
ROICexgc growth 3Y-59.71%
ROICexgc growth 5Y-22%
ROICexc growth 3Y-59.75%
ROICexc growth 5Y-22.29%
OM growth 3Y-52.33%
OM growth 5Y-23.53%
PM growth 3Y-21.71%
PM growth 5Y2.56%
GM growth 3Y-10.36%
GM growth 5Y-1.5%
F-Score4
Asset Turnover1.69
Health
Industry RankSector Rank
Debt/Equity 0.32
Debt/FCF N/A
Debt/EBITDA 4.81
Cap/Depr 96.64%
Cap/Sales 1.86%
Interest Coverage 250
Cash Conversion 79.1%
Profit Quality N/A
Current Ratio 1.42
Quick Ratio 0.8
Altman-Z 2.1
F-Score4
WACC5.45%
ROIC/WACC0.07
Cap/Depr(3y)119.46%
Cap/Depr(5y)96.76%
Cap/Sales(3y)1.78%
Cap/Sales(5y)1.38%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)N/A
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-5.74%
Revenue growth 3Y-9.47%
Revenue growth 5Y4.54%
Sales Q2Q%-4.63%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-77.46%
EBIT growth 3Y-56.84%
EBIT growth 5Y-20.06%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-102.18%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-82.15%
OCF growth 3Y-31.13%
OCF growth 5Y-10.17%

CHS INC - CHSINC 7.1 PERP / CHSCN FAQ

What is the ChartMill fundamental rating of CHS INC - CHSINC 7.1 PERP (CHSCN) stock?

ChartMill assigns a fundamental rating of 3 / 10 to CHSCN.


What is the valuation status for CHSCN stock?

ChartMill assigns a valuation rating of 1 / 10 to CHS INC - CHSINC 7.1 PERP (CHSCN). This can be considered as Overvalued.


What is the profitability of CHSCN stock?

CHS INC - CHSINC 7.1 PERP (CHSCN) has a profitability rating of 4 / 10.


Can you provide the financial health for CHSCN stock?

The financial health rating of CHS INC - CHSINC 7.1 PERP (CHSCN) is 3 / 10.